Global GLP-1 Receptor Agonists Market Growth (Status and Outlook) 2025-2031

September 2025 | 100 pages | ID: G9C34C457884EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global GLP-1 Receptor Agonists market size will reach US$ million by 2031.

United States market for GLP-1 Receptor Agonists is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for GLP-1 Receptor Agonists is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for GLP-1 Receptor Agonists is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key GLP-1 Receptor Agonists players cover GSK, Novo Nordisk, Lily, Haosoh, Sanofi, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “GLP-1 Receptor Agonists Industry Forecast” looks at past sales and reviews total world GLP-1 Receptor Agonists sales in 2024, providing a comprehensive analysis by region and market sector of projected GLP-1 Receptor Agonists sales for 2025 through 2031. With GLP-1 Receptor Agonists sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Receptor Agonists industry.

This Insight Report provides a comprehensive analysis of the global GLP-1 Receptor Agonists landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on GLP-1 Receptor Agonists portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Receptor Agonists market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Receptor Agonists and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Receptor Agonists.

This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Receptor Agonists market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Exenatide
  • Liraglutide
  • Lixisenatide
  • Albiglutide
  • Others
Segmentation by Application:
  • Solid Tumors
  • Blood-related Tumors
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • GSK
  • Novo Nordisk
  • Lily
  • Haosoh
  • Sanofi
  • AstraZeneca
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global GLP-1 Receptor Agonists Market Size (2020-2031)
  2.1.2 GLP-1 Receptor Agonists Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for GLP-1 Receptor Agonists by Country/Region (2020, 2024 & 2031)
2.2 GLP-1 Receptor Agonists Segment by Type
  2.2.1 Exenatide
  2.2.2 Liraglutide
  2.2.3 Lixisenatide
  2.2.4 Albiglutide
  2.2.5 Others
2.3 GLP-1 Receptor Agonists Market Size by Type
  2.3.1 GLP-1 Receptor Agonists Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global GLP-1 Receptor Agonists Market Size Market Share by Type (2020-2025)
2.4 GLP-1 Receptor Agonists Segment by Application
  2.4.1 Solid Tumors
  2.4.2 Blood-related Tumors
2.5 GLP-1 Receptor Agonists Market Size by Application
  2.5.1 GLP-1 Receptor Agonists Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global GLP-1 Receptor Agonists Market Size Market Share by Application (2020-2025)

3 GLP-1 RECEPTOR AGONISTS MARKET SIZE BY PLAYER

3.1 GLP-1 Receptor Agonists Market Size Market Share by Player
  3.1.1 Global GLP-1 Receptor Agonists Revenue by Player (2020-2025)
  3.1.2 Global GLP-1 Receptor Agonists Revenue Market Share by Player (2020-2025)
3.2 Global GLP-1 Receptor Agonists Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GLP-1 RECEPTOR AGONISTS BY REGION

4.1 GLP-1 Receptor Agonists Market Size by Region (2020-2025)
4.2 Global GLP-1 Receptor Agonists Annual Revenue by Country/Region (2020-2025)
4.3 Americas GLP-1 Receptor Agonists Market Size Growth (2020-2025)
4.4 APAC GLP-1 Receptor Agonists Market Size Growth (2020-2025)
4.5 Europe GLP-1 Receptor Agonists Market Size Growth (2020-2025)
4.6 Middle East & Africa GLP-1 Receptor Agonists Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas GLP-1 Receptor Agonists Market Size by Country (2020-2025)
5.2 Americas GLP-1 Receptor Agonists Market Size by Type (2020-2025)
5.3 Americas GLP-1 Receptor Agonists Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC GLP-1 Receptor Agonists Market Size by Region (2020-2025)
6.2 APAC GLP-1 Receptor Agonists Market Size by Type (2020-2025)
6.3 APAC GLP-1 Receptor Agonists Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe GLP-1 Receptor Agonists Market Size by Country (2020-2025)
7.2 Europe GLP-1 Receptor Agonists Market Size by Type (2020-2025)
7.3 Europe GLP-1 Receptor Agonists Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa GLP-1 Receptor Agonists by Region (2020-2025)
8.2 Middle East & Africa GLP-1 Receptor Agonists Market Size by Type (2020-2025)
8.3 Middle East & Africa GLP-1 Receptor Agonists Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GLP-1 RECEPTOR AGONISTS MARKET FORECAST

10.1 Global GLP-1 Receptor Agonists Forecast by Region (2026-2031)
  10.1.1 Global GLP-1 Receptor Agonists Forecast by Region (2026-2031)
  10.1.2 Americas GLP-1 Receptor Agonists Forecast
  10.1.3 APAC GLP-1 Receptor Agonists Forecast
  10.1.4 Europe GLP-1 Receptor Agonists Forecast
  10.1.5 Middle East & Africa GLP-1 Receptor Agonists Forecast
10.2 Americas GLP-1 Receptor Agonists Forecast by Country (2026-2031)
  10.2.1 United States Market GLP-1 Receptor Agonists Forecast
  10.2.2 Canada Market GLP-1 Receptor Agonists Forecast
  10.2.3 Mexico Market GLP-1 Receptor Agonists Forecast
  10.2.4 Brazil Market GLP-1 Receptor Agonists Forecast
10.3 APAC GLP-1 Receptor Agonists Forecast by Region (2026-2031)
  10.3.1 China GLP-1 Receptor Agonists Market Forecast
  10.3.2 Japan Market GLP-1 Receptor Agonists Forecast
  10.3.3 Korea Market GLP-1 Receptor Agonists Forecast
  10.3.4 Southeast Asia Market GLP-1 Receptor Agonists Forecast
  10.3.5 India Market GLP-1 Receptor Agonists Forecast
  10.3.6 Australia Market GLP-1 Receptor Agonists Forecast
10.4 Europe GLP-1 Receptor Agonists Forecast by Country (2026-2031)
  10.4.1 Germany Market GLP-1 Receptor Agonists Forecast
  10.4.2 France Market GLP-1 Receptor Agonists Forecast
  10.4.3 UK Market GLP-1 Receptor Agonists Forecast
  10.4.4 Italy Market GLP-1 Receptor Agonists Forecast
  10.4.5 Russia Market GLP-1 Receptor Agonists Forecast
10.5 Middle East & Africa GLP-1 Receptor Agonists Forecast by Region (2026-2031)
  10.5.1 Egypt Market GLP-1 Receptor Agonists Forecast
  10.5.2 South Africa Market GLP-1 Receptor Agonists Forecast
  10.5.3 Israel Market GLP-1 Receptor Agonists Forecast
  10.5.4 Turkey Market GLP-1 Receptor Agonists Forecast
10.6 Global GLP-1 Receptor Agonists Forecast by Type (2026-2031)
10.7 Global GLP-1 Receptor Agonists Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market GLP-1 Receptor Agonists Forecast

11 KEY PLAYERS ANALYSIS

11.1 GSK
  11.1.1 GSK Company Information
  11.1.2 GSK GLP-1 Receptor Agonists Product Offered
  11.1.3 GSK GLP-1 Receptor Agonists Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 GSK Main Business Overview
  11.1.5 GSK Latest Developments
11.2 Novo Nordisk
  11.2.1 Novo Nordisk Company Information
  11.2.2 Novo Nordisk GLP-1 Receptor Agonists Product Offered
  11.2.3 Novo Nordisk GLP-1 Receptor Agonists Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Novo Nordisk Main Business Overview
  11.2.5 Novo Nordisk Latest Developments
11.3 Lily
  11.3.1 Lily Company Information
  11.3.2 Lily GLP-1 Receptor Agonists Product Offered
  11.3.3 Lily GLP-1 Receptor Agonists Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Lily Main Business Overview
  11.3.5 Lily Latest Developments
11.4 Haosoh
  11.4.1 Haosoh Company Information
  11.4.2 Haosoh GLP-1 Receptor Agonists Product Offered
  11.4.3 Haosoh GLP-1 Receptor Agonists Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Haosoh Main Business Overview
  11.4.5 Haosoh Latest Developments
11.5 Sanofi
  11.5.1 Sanofi Company Information
  11.5.2 Sanofi GLP-1 Receptor Agonists Product Offered
  11.5.3 Sanofi GLP-1 Receptor Agonists Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sanofi Main Business Overview
  11.5.5 Sanofi Latest Developments
11.6 AstraZeneca
  11.6.1 AstraZeneca Company Information
  11.6.2 AstraZeneca GLP-1 Receptor Agonists Product Offered
  11.6.3 AstraZeneca GLP-1 Receptor Agonists Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 AstraZeneca Main Business Overview
  11.6.5 AstraZeneca Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. GLP-1 Receptor Agonists Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. GLP-1 Receptor Agonists Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Exenatide
Table 4. Major Players of Liraglutide
Table 5. Major Players of Lixisenatide
Table 6. Major Players of Albiglutide
Table 7. Major Players of Others
Table 8. GLP-1 Receptor Agonists Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global GLP-1 Receptor Agonists Market Size by Type (2020-2025) & ($ millions)
Table 10. Global GLP-1 Receptor Agonists Market Size Market Share by Type (2020-2025)
Table 11. GLP-1 Receptor Agonists Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global GLP-1 Receptor Agonists Market Size by Application (2020-2025) & ($ millions)
Table 13. Global GLP-1 Receptor Agonists Market Size Market Share by Application (2020-2025)
Table 14. Global GLP-1 Receptor Agonists Revenue by Player (2020-2025) & ($ millions)
Table 15. Global GLP-1 Receptor Agonists Revenue Market Share by Player (2020-2025)
Table 16. GLP-1 Receptor Agonists Key Players Head office and Products Offered
Table 17. GLP-1 Receptor Agonists Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global GLP-1 Receptor Agonists Market Size by Region (2020-2025) & ($ millions)
Table 21. Global GLP-1 Receptor Agonists Market Size Market Share by Region (2020-2025)
Table 22. Global GLP-1 Receptor Agonists Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global GLP-1 Receptor Agonists Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas GLP-1 Receptor Agonists Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas GLP-1 Receptor Agonists Market Size Market Share by Country (2020-2025)
Table 26. Americas GLP-1 Receptor Agonists Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas GLP-1 Receptor Agonists Market Size Market Share by Type (2020-2025)
Table 28. Americas GLP-1 Receptor Agonists Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas GLP-1 Receptor Agonists Market Size Market Share by Application (2020-2025)
Table 30. APAC GLP-1 Receptor Agonists Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC GLP-1 Receptor Agonists Market Size Market Share by Region (2020-2025)
Table 32. APAC GLP-1 Receptor Agonists Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC GLP-1 Receptor Agonists Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe GLP-1 Receptor Agonists Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe GLP-1 Receptor Agonists Market Size Market Share by Country (2020-2025)
Table 36. Europe GLP-1 Receptor Agonists Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe GLP-1 Receptor Agonists Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa GLP-1 Receptor Agonists Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa GLP-1 Receptor Agonists Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa GLP-1 Receptor Agonists Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of GLP-1 Receptor Agonists
Table 42. Key Market Challenges & Risks of GLP-1 Receptor Agonists
Table 43. Key Industry Trends of GLP-1 Receptor Agonists
Table 44. Global GLP-1 Receptor Agonists Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global GLP-1 Receptor Agonists Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global GLP-1 Receptor Agonists Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global GLP-1 Receptor Agonists Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. GSK Details, Company Type, GLP-1 Receptor Agonists Area Served and Its Competitors
Table 49. GSK GLP-1 Receptor Agonists Product Offered
Table 50. GSK GLP-1 Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. GSK Main Business
Table 52. GSK Latest Developments
Table 53. Novo Nordisk Details, Company Type, GLP-1 Receptor Agonists Area Served and Its Competitors
Table 54. Novo Nordisk GLP-1 Receptor Agonists Product Offered
Table 55. Novo Nordisk GLP-1 Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Novo Nordisk Main Business
Table 57. Novo Nordisk Latest Developments
Table 58. Lily Details, Company Type, GLP-1 Receptor Agonists Area Served and Its Competitors
Table 59. Lily GLP-1 Receptor Agonists Product Offered
Table 60. Lily GLP-1 Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Lily Main Business
Table 62. Lily Latest Developments
Table 63. Haosoh Details, Company Type, GLP-1 Receptor Agonists Area Served and Its Competitors
Table 64. Haosoh GLP-1 Receptor Agonists Product Offered
Table 65. Haosoh GLP-1 Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Haosoh Main Business
Table 67. Haosoh Latest Developments
Table 68. Sanofi Details, Company Type, GLP-1 Receptor Agonists Area Served and Its Competitors
Table 69. Sanofi GLP-1 Receptor Agonists Product Offered
Table 70. Sanofi GLP-1 Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Sanofi Main Business
Table 72. Sanofi Latest Developments
Table 73. AstraZeneca Details, Company Type, GLP-1 Receptor Agonists Area Served and Its Competitors
Table 74. AstraZeneca GLP-1 Receptor Agonists Product Offered
Table 75. AstraZeneca GLP-1 Receptor Agonists Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. AstraZeneca Main Business
Table 77. AstraZeneca Latest Developments

LIST OF FIGURES

Figure 1. GLP-1 Receptor Agonists Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global GLP-1 Receptor Agonists Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. GLP-1 Receptor Agonists Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. GLP-1 Receptor Agonists Sales Market Share by Country/Region (2024)
Figure 8. GLP-1 Receptor Agonists Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global GLP-1 Receptor Agonists Market Size Market Share by Type in 2024
Figure 10. GLP-1 Receptor Agonists in Solid Tumors
Figure 11. Global GLP-1 Receptor Agonists Market: Solid Tumors (2020-2025) & ($ millions)
Figure 12. GLP-1 Receptor Agonists in Blood-related Tumors
Figure 13. Global GLP-1 Receptor Agonists Market: Blood-related Tumors (2020-2025) & ($ millions)
Figure 14. Global GLP-1 Receptor Agonists Market Size Market Share by Application in 2024
Figure 15. Global GLP-1 Receptor Agonists Revenue Market Share by Player in 2024
Figure 16. Global GLP-1 Receptor Agonists Market Size Market Share by Region (2020-2025)
Figure 17. Americas GLP-1 Receptor Agonists Market Size 2020-2025 ($ millions)
Figure 18. APAC GLP-1 Receptor Agonists Market Size 2020-2025 ($ millions)
Figure 19. Europe GLP-1 Receptor Agonists Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa GLP-1 Receptor Agonists Market Size 2020-2025 ($ millions)
Figure 21. Americas GLP-1 Receptor Agonists Value Market Share by Country in 2024
Figure 22. United States GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC GLP-1 Receptor Agonists Market Size Market Share by Region in 2024
Figure 27. APAC GLP-1 Receptor Agonists Market Size Market Share by Type (2020-2025)
Figure 28. APAC GLP-1 Receptor Agonists Market Size Market Share by Application (2020-2025)
Figure 29. China GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 33. India GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe GLP-1 Receptor Agonists Market Size Market Share by Country in 2024
Figure 36. Europe GLP-1 Receptor Agonists Market Size Market Share by Type (2020-2025)
Figure 37. Europe GLP-1 Receptor Agonists Market Size Market Share by Application (2020-2025)
Figure 38. Germany GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 39. France GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 40. UK GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa GLP-1 Receptor Agonists Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa GLP-1 Receptor Agonists Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa GLP-1 Receptor Agonists Market Size Market Share by Application (2020-2025)
Figure 46. Egypt GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries GLP-1 Receptor Agonists Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 52. APAC GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 53. Europe GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 55. United States GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 56. Canada GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 57. Mexico GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 58. Brazil GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 59. China GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 60. Japan GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 61. Korea GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 63. India GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 64. Australia GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 65. Germany GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 66. France GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 67. UK GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 68. Italy GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 69. Russia GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 70. Egypt GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 71. South Africa GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 72. Israel GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 73. Turkey GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)
Figure 74. Global GLP-1 Receptor Agonists Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global GLP-1 Receptor Agonists Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries GLP-1 Receptor Agonists Market Size 2026-2031 ($ millions)


More Publications

Global Buccal Swab Market Growth 2024-2030 US$ 3,660.00 March 2024 116 pages
Global Biochips Market Growth 2024-2030 US$ 3,660.00 November 2024 118 pages
Global Therapeutic Enzymes Market Growth 2025-2031 US$ 3,660.00 January 2025 118 pages